Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Outcomes by treatment-emergent ascites

Kudo, M; Ikeda, M; Galle, PR; Yamashita, T; Finn, RS; Liang, K; Wang, CX; Sakaguchi, S; Abada, P; Widau, RC; Zhu, AX

Zhu, AX (corresponding author), Massachusetts Gen Hosp, Canc Ctr, 55 Fruit St, Boston, MA 02114 USA.; Kudo, M (corresponding author), Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.

HEPATOLOGY RESEARCH, 2021; 51 (6): 715

Abstract

Aim The REACH and REACH-2 trials investigated ramucirumab versus placebo in patients with advanced hepatocellular carcinoma (HCC). Ascites is common i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索